Halo is well diversified which i see as a good thing for shareholders.
In FY22:
The NZ business was EBITDA profitable.
The Australian business was EBITDA profitable
Brands was unprofitable
The group was EBITDA profitable on a normalised basis
In FY23 so far even it’s (somewhat underwritten) Brands business (in its infancy with some good momentum) was EBITDA profitable last quarter. Just the Tonik brand alone, for which there seems to be a much better focus, has some great potential.
Recent M&A interest in the health space - of which some provide some encouraging valuations:
- The Man Shake (reported at $400m)
- Clif Bar (reported at $2.9bn)
- Bodyscience (undisclosed)
- Laird superfoods ($42m - low revenue and loss making)
HLF Price at posting:
4.6¢ Sentiment: Buy Disclosure: Held
(20min delay)